Key result
VEGF-D plasma levels were significantly higher in elderly patients with cardiovascular disease and heart failure (P < .01) and positively correlated with NT-pro BNP (P < .001).
Why the study?
To evaluate the clinical significance of VEGF subtypes and GDF-15 plasma levels for assessing fluid overload and cardiac function in elderly patients with cardiovascular disease.
Do plasma levels of VEGF subtypes and GDF-15 correlate with fluid overload and cardiac function in elderly patients with cardiovascular disease?
Observational
Do plasma levels of VEGF subtypes and GDF-15 correlate with fluid overload and cardiac function in elderly patients with cardiovascular disease?
p-value: p=< .01
VEGF-D plasma levels serve as a potential biomarker for evaluating fluid overload and cardiac function in elderly patients with cardiovascular disease.
May inform fluid overload assessment in elderly CVD patients; hypothesis-generating and requires prospective validation.
This study aimed to investigate the clinical significance of vascular endothelial growth factor (VEGF) subtypes and growth differentiation factor-15 (GDF-15) plasma levels in evaluating the fluid overload and cardiac function of elderly patients with cardiovascular disease. The plasma levels of VEGF-C, VEGF-D, and GDF-15 were measured using ELISA. Their correlations with N-terminal pro B-type natriuretic peptide (NT-Pro BNP) and echocardiography data were analyzed. 1. Higher plasma levels of VEGF-D and GDF-15 were observed in elderly patients with cardiovascular disease and heart failure(P < .01). VEGF-D plasma levels were higher in patients with chronic heart failure than those with acute myocardial infarction (P < .01). VEGF-D plasma levels were positively correlated with amino-terminal pro-B type natriuretic peptide (NT-pro BNP) (P < .001). VEGF-D plasma levels were positively correlated with echocardiographic parameters, including left atrial diameter, left ventricular end-diastolic diameter and left ventricular ejection fraction, in patients with cardiovascular disease (P < .01). 2. VEGF-C plasma levels were higher in acute myocardial infarction group (P < .05). The plasma levels of VEGF-C were not correlated with either VEGF-D or NT-pro BNP plasma levels. VEGF-C plasma levels had no correlation with echocardiographic parameters. 3. GDF-15 plasma levels were positively correlated with sera biomarkers of cardiac injury (creatine kinase isoenzyme MB and cardiac troponin I). GDF-15 plasma levels were positively correlated with urinary biomarkers of tubular injury (N-acetyl-β-galactosidase and α1-microglobulin). Both GDF-15 and NT-pro BNP plasma levels were correlated with age, estimated glomerular filtration rate (eGFR), and nutritional biomarkers (albumin and hemoglobin plasma levels). VEGF-D plasma levels is a potential biomarker of fluid overload and cardiac function in elderly patients with cardiovascular disease. Age, nutrition, and kidney injury are factors influencing both GDF-15 and NT-pro BNP plasma levels in estimating cardiac function and fluid overload.
No takes yet. Share an insight, caveat, or question.
Li et al. (2023) conducted an observational in Cardiovascular disease. VEGF-D, VEGF-C, and GDF-15 plasma levels was evaluated on Correlation with NT-Pro BNP and echocardiography data (p=< .01). VEGF-D plasma levels were significantly higher in elderly patients with cardiovascular disease and heart failure (P < .01) and positively correlated with NT-pro BNP (P < .001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: